Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy.
Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP; DCCT/EDIC Research Group. Grassi MA, et al. Among authors: cleary pa. Ophthalmology. 2013 Dec;120(12):2580-2586. doi: 10.1016/j.ophtha.2013.06.002. Epub 2013 Jul 24. Ophthalmology. 2013. PMID: 23890420 Free PMC article. Clinical Trial.
Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Hubbard LD, et al. Among authors: cleary pa. Arch Ophthalmol. 2011 Jun;129(6):718-26. doi: 10.1001/archophthalmol.2011.136. Arch Ophthalmol. 2011. PMID: 21670338 Clinical Trial.
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM. White NH, et al. Among authors: cleary pa. Arch Ophthalmol. 2008 Dec;126(12):1707-15. doi: 10.1001/archopht.126.12.1707. Arch Ophthalmol. 2008. PMID: 19064853 Free PMC article. Clinical Trial.
Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Lorenzi GM, Braffett BH, Arends VL, Danis RP, Diminick L, Klumpp KA, Morrison AD, Soliman EZ, Steffes MW, Cleary PA; DCCT/EDIC Research Group. Lorenzi GM, et al. Among authors: cleary pa. PLoS One. 2015 Nov 3;10(11):e0141286. doi: 10.1371/journal.pone.0141286. eCollection 2015. PLoS One. 2015. PMID: 26529311 Free PMC article. Clinical Trial.
Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
Writing Team for the DCCT/EDIC Research Group; Gubitosi-Klug RA, Sun W, Cleary PA, Braffett BH, Aiello LP, Das A, Tamborlane W, Klein R. Writing Team for the DCCT/EDIC Research Group, et al. Among authors: cleary pa. JAMA Ophthalmol. 2016 Feb;134(2):137-45. doi: 10.1001/jamaophthalmol.2015.4606. JAMA Ophthalmol. 2016. PMID: 26584339 Free PMC article. Clinical Trial.
Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
Younes N, Cleary PA, Steffes MW, de Boer IH, Molitch ME, Rutledge BN, Lachin JM, Dahms W; DCCT/EDIC Research Group. Younes N, et al. Among authors: cleary pa. Clin J Am Soc Nephrol. 2010 Jul;5(7):1235-42. doi: 10.2215/CJN.07901109. Epub 2010 May 6. Clin J Am Soc Nephrol. 2010. PMID: 20448066 Free PMC article. Clinical Trial.
171 results